Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors. ESMO Open.

Investigación y Educación

Background Human papilloma virus (HPV) has been associated with the development and modulation of response in a series of neoplasms. In the case of lung adenocarcinoma, its role in etiology and pathogenesis is still controversial. Considering that this infection brings foreign epitopes, it could be of prognostic significance in patients with lung adenocarcinoma treated with immunotherapy.

Conclusions In patients with HPV+ lung adenocarcinoma, a significant benefit in overall response and survival outcomes is observed.

Read full article

Artículos que te pueden interesar

Oncología

Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and Nivolumab. Front Oncol.

Enero 5, 2022

Leer más

Oncología

KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block. Ther Adv Respir Dis.

Enero 31, 2022

Leer más

Oncología

p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics. Transl Oncol.

Noviembre 22, 2021

Leer más